3Gurkan S, Seber S, Gur O, et al. Retrospective evaluation of totally implantable venous access port devices early and late complications[J]. J BUON, 2015, 20 (1) 338.
4Bassi KK, Girl AK, Pattanayak M, et al. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients[J]. Indian J Cancer, 2012, 49 (1): ll4.
5Vescia S, Baumgartner AK, Jacobs VR, et al. Management of venous port systems in oncology., a review of current evidence[J]. Ann Oncol, 2008, 19 (1).. 9.
6Ji L, Yang J, Miao J, et al. Infections related to totally implantable venous-access ports., long-term experience in one center[J]. Cell Biochem Biophys, 2015, 72 (1): 235.
4Di Carlo I, Pulvirenti E, Mannino M. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications [J]. Ann Surg Oncol, 2010,17(6) : 1649-1656.
5Knebel P, Lopez-Benitez R, Fischer L, et al. Insertion of totally implantable venous access devices: an expertise-based, randomized, controlled trial (NCT00600444) [J]. Ann Surg , 2011,253(6) : 1111-1117.
6Tannouri F, Chahine G, Elias E,et al. Ultrasonography and fluoroscopy-guided insertion of subcutaneous intravenous infusion port. Prospective study over 120 patients [J]. J Med Liban,2010 58(4) : 187-190.
7Ribeiro R C, Abib S C, Aguiar A S, et al. Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture [J]. Pediatr Blood Cancer,2012,58 (2): 274-277.
